Truncated mu opioid GPCR variant involvement in opioid-dependent and opioid-independent pain modulatory systems within the CNS

Authors:

Abstract
Significance: Many classes of G protein-coupled receptors (GPCRs) produce truncated variants. Truncated forms of the mu opioid receptor geneOprm1containing only six transmembrane domains (6TM) can mediate a potent analgesia without producing many classical opioid side effects. We now show that 6TMOprm1splice variants are essential in the analgesic actions of delta and kappa opioids as well as α2adrenergic drugs, but not neurotensin, cannabinoids, or muscarinic drugs. The role of the 6TM variants seems limited to analgesia because they are not involved with kappa aversion, delta-induced seizure activity, or α2adrenergic hypolocomotion. These findings emphasize the importance of 6TMOprm1variants in opioid and nonopioid sensory processing and illustrate the potential importance of the vast array of other classes of truncated GPCR variants.
Funding Information
  • HHS | NIH | National Institute on Drug Abuse (DA06241)
  • HHS | NIH | National Cancer Institute (CA08748)
  • National Science Foundation (DGE-1257284)
  • HHS | NIH | National Institute on Drug Abuse (DA07242)

This publication has 34 references indexed in Scilit: